The Benefit of Short-Term Androgen Deprivation Therapy with Radiotherapy for Intermediate-Risk Prostate Cancer - Beyond ...
Historically, short-term androgen deprivation therapy (ST-ADT) has been considered a mainstay of treatment for intermediate-risk prostate cancer (IR-PCa) based upon early randomized controlled trials (RCTs) such as DFCI 95-096 and NRG/RTOG 9408. In …